Boehringer Ingelheim Pharmaceuticals
Director, Patient Advocacy & Professional Relations Cardiovascular, Metabolic, Respiratory & IPF
About: Boehringer Ingelheim Pharmaceuticals, the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally in 45 countries with more than 34,000 employees. The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. For more information please visit www.boehringer-ingelheim.com.